← Leaderboards
Enrique Saez
Scripps Research Institute, The
$14,086,731
Attributed
$22,059,772
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2008–25$2.5M$1.9M$1.3M$625K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,059,772 · 9
By mechanism
R01$8,469,543 · 5
RC2$8,249,685 · 1
R24$4,718,329 · 1
R21$447,197 · 1
S10$175,018 · 1
Top collaborators
- Benjamin F Cravatt9 shared
- Laszlo Nagy2 shared
- Rockland L Wiseman2 shared
Most similar at Scripps Research Institute, The
Same institution · by research overlap
- William Edward Balch$38,266,165
- Jin-Quan Yu$14,956,760
- Dale L Boger$41,942,040
- John Robert Yates$49,942,444
- Dwight H Kono$16,810,974
Others in their field
Top investigators on “Lipids”
- Constance Ann Benson · University Of California, San Diego$84,289,569
- Alan M Fogelman · University Of California Los Angeles$57,458,120
- Paul M. Ridker · Brigham And Women'S Hospital$56,179,451
- Adrian Hernandez · Duke University$50,769,596
- Garret A Fitzgerald · University Of Pennsylvania$50,340,498
- Richard A Gibbs · Baylor College Of Medicine$49,140,324
Research focus
LipidsCellsCell PhysiologyMetabolicLinkIn VivoTissuesMolecularPathway InteractionsDiabetes MellitusSignal TransductionNon-Insulin-Dependent Diabetes MellitusObesityBaseGeneticAdipocytesLiverEnzymesPhysiologicalPlayAdipose TissueInsulinMetabolic DiseasesMetabolism
Grant awards (29)
Intracellular trafficking of the essential signaling metabolite heme in myeloid cells: impact on physiology and disease$754,755
R01 · FY2025 · DK · contact PI
Pharmacologic targeting of the UPR in obesity-linked liver dysfunction$689,587
R01 · FY2025 · DK · contact PI
Intracellular trafficking of the essential signaling metabolite heme in myeloid cells: impact on physiology and disease$780,012
R01 · FY2024 · DK · contact PI
Pharmacologic targeting of the UPR in obesity-linked liver dysfunction$753,715
R01 · FY2024 · DK · contact PI
Impact of Heme Homeostasis on Adipocyte Function$508,725
R01 · FY2022 · DK · contact PI
Chemoproteomic Identification and Therapeutic Validation of Proteins of Metabolic Significance$1,640,587
RC2 · FY2021 · DK · contact PI
Impact of Heme Homeostasis on Adipocyte Function$525,229
R01 · FY2021 · DK · contact PI
Chemoproteomic Identification and Therapeutic Validation of Proteins of Metabolic Significance$1,640,587
RC2 · FY2020 · DK · contact PI
Impact of Heme Homeostasis on Adipocyte Function$528,733
R01 · FY2020 · DK · contact PI
Chemoproteomic Identification and Therapeutic Validation of Proteins of Metabolic Significance$1,640,587
RC2 · FY2019 · DK · contact PI
Impact of Heme Homeostasis on Adipocyte Function$552,375
R01 · FY2019 · DK · contact PI
Chemoproteomic Identification and Therapeutic Validation of Proteins of Metabolic Significance$1,640,587
RC2 · FY2018 · DK · contact PI
Chemoproteomic Identification and Therapeutic Validation of Proteins of Metabolic Significance$1,687,337
RC2 · FY2017 · DK · contact PI
Identification and Therapeutic Valiation of Adipocyte Serine Hydrolases of Metab$1,384,096
R24 · FY2016 · DK · contact PI
Identification and Therapeutic Valiation of Adipocyte Serine Hydrolases of Metab$1,379,304
R24 · FY2015 · DK · contact PI
Identification and Therapeutic Valiation of Adipocyte Serine Hydrolases of Metab$1,089,929
R24 · FY2014 · DK · contact PI
Targeting Adipocyte Lipases to Treat Pancreatic Cancer-Associated Cachexia$199,899
R21 · FY2014 · CA · contact PI
Identification and Therapeutic Valiation of Adipocyte Serine Hydrolases of Metab$865,000
R24 · FY2013 · DK · contact PI
Targeting Adipocyte Lipases to Treat Pancreatic Cancer-Associated Cachexia$247,298
R21 · FY2013 · CA · contact PI
Seahorse XF96 Extracellular Flux Analyzer$175,018
S10 · FY2013 · OD · contact PI
A Genome-wide RNAi Screening Platform for the Common Lab$372,242
R01 · FY2012 · GM · contact PI
Nuclear Receptor Control of Glucose and Lipid Metabolism$371,458
R01 · FY2012 · DK · contact PI
A Genome-wide RNAi Screening Platform for the Common Lab$372,242
R01 · FY2011 · GM · contact PI
Nuclear Receptor Control of Glucose and Lipid Metabolism$371,458
R01 · FY2011 · DK · contact PI
A Genome-wide RNAi Screening Platform for the Common Lab$376,002
R01 · FY2010 · GM · contact PI
Nuclear Receptor Control of Glucose and Lipid Metabolism$375,210
R01 · FY2010 · DK · contact PI
A Genome-wide RNAi Screening Platform for the Common Lab$379,800
R01 · FY2009 · GM · contact PI
Nuclear Receptor Control of Glucose and Lipid Metabolism$379,000
R01 · FY2009 · DK · contact PI
Nuclear Receptor Control of Glucose and Lipid Metabolism$379,000
R01 · FY2008 · DK · contact PI